RNA
#3723
Atrium Therapeutics, Inc. - Common Stock
7.6 8 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.90%
Changement Mensuel
-24.04%
Evolution sur 6 mois
-46.89%
Changement Annuel
-89.08%
Clôture Précédente
7.7 5
Open
7.7 5
Low
7.5 4
High
7.9 4
Financials
- Market Capitalization 131.37 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3711 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.43 USD | -2.72% | -5.30% | -23.12% | -35.29% | 134.02 M USD | ||
| 3714 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 3.54 USD | -1.67% | -25.79% | -34.20% | +187.80% | 133.59 M USD | ||
| 3726 |  KRRO Korro Bio, Inc. - Common Stock | 8.88 USD | +0.79% | -14.29% | -37.24% | -77.17% | 130.76 M USD | ||
| 3737 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 1.75 USD | -3.85% | -16.27% | -40.07% | -23.25% | 126.56 M USD |